Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in Br J Surg

Retrieve available abstracts of 164 articles:
HTML format



Single Articles


    July 2021
  1. EBBEHOJ AL, Jorgensen LN, Krarup PM, Smith HG, et al
    Histopathological risk factors for lymph node metastases in T1 colorectal cancer: meta-analysis.
    Br J Surg. 2021 Jul 9. pii: 6304963. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  2. SPYCHALSKI M, Wlodarczyk M, Winter K
    Impact of COVID-19 pandemic on endoscopic submucosal dissection outcomes in early colorectal tumours.
    Br J Surg. 2021;108:e224-e225.
    PubMed    


  3. GONELLA F, Massucco P, Perotti S, Monasterolo S, et al
    Telemedicine prehabilitation as a result of COVID-19: disruptive technological solutions.
    Br J Surg. 2021;108:e215-e216.
    PubMed    


    May 2021
  4. DE HINGH IHJT
    Heated intraperitoneal chemotherapy for colorectal cancer: game over or game on?
    Br J Surg. 2021 May 10. pii: 6273040. doi: 10.1093.
    PubMed    


    April 2021
  5. DONG DZ, Dong QS, Zhang FN, Li CL, et al
    Impact of COVID-19 on treatment modalities and short-term outcomes of rectal cancer following neoadjuvant chemoradiotherapy: a retrospective study.
    Br J Surg. 2021;108:e164-e165.
    PubMed    


  6. ABDELLATIF M, Salama Y, Alhammali T, Eltweri AM, et al
    Impact of COVID-19 on colorectal cancer early diagnosis pathway: retrospective cohort study.
    Br J Surg. 2021 Apr 1. pii: 6207608. doi: 10.1093.
    PubMed    


    March 2021
  7. AGUIAR S, Riechelmann RP, de Mello CAL, da Silva JCF, et al
    Impact of COVID-19 on colorectal cancer presentation.
    Br J Surg. 2021;108:e81-e82.
    PubMed    


  8. WANG X, Zheng Z, Yu Q, Huang Y, et al
    Do young patients with rectal cancer have outcomes comparable to those of their older counterparts? A statistical problem and countermeasure.
    Br J Surg. 2021;108:e83.
    PubMed    


  9. SCHAAP DP, Boogerd LSF, Konishi T, Cunningham C, et al
    Rectal cancer lateral lymph nodes: multicentre study of the impact of obturator and internal iliac nodes on oncological outcomes.
    Br J Surg. 2021;108:205-213.
    PubMed     Abstract available


  10. FLEMING CA, Cullinane C, Lynch N, Killeen S, et al
    Urogenital function following robotic and laparoscopic rectal cancer surgery: meta-analysis.
    Br J Surg. 2021;108:128-137.
    PubMed     Abstract available


  11. LAU S, Kong J, Bell S, Heriot A, et al
    Transanal mesorectal excision: early outcomes in Australia and New Zealand.
    Br J Surg. 2021;108:214-219.
    PubMed     Abstract available


    January 2021
  12. ABDULKARIM A, Barasa M
    Clinicopathological profile of colorectal cancer at a tertiary hospital in Kenya.
    Br J Surg. 2021 Jan 31. pii: 6124826. doi: 10.1093.
    PubMed    


  13. HABIB BEDWANI N, English W, Coda S, Akinlade F, et al
    Developing a prioritization model for endoscopy and colorectal cancer 2-week wait referrals during the COVID-19 pandemic-is faecal immunochemical testing the answer?
    Br J Surg. 2021;108:e18-e19.
    PubMed    


  14. CAHILL RA, O'Shea DF, Khan MF, Khokhar HA, et al
    Artificial intelligence indocyanine green (ICG) perfusion for colorectal cancer intra-operative tissue classification.
    Br J Surg. 2021;108:5-9.
    PubMed    


  15. ROCKALL TA
    Transanal total mesorectal excision: the race to the bottom.
    Br J Surg. 2021;108:3-4.
    PubMed    


  16. ROUANET P, Rivoire M, Gourgou S, Lelong B, et al
    Sphincter-saving surgery after neoadjuvant therapy for ultra-low rectal cancer where abdominoperineal resection was indicated: 10-year results of the GRECCAR 1 trial.
    Br J Surg. 2021;108:10-13.
    PubMed    


  17. TOLLEY T, Whewell H, Davies DR, Codd RJ, et al
    Colorectal cancer referrals during the COVID-19 pandemic: the utility of CT and faecal immunochemical testing.
    Br J Surg. 2021 Jan 25. pii: 6120047. doi: 10.1093.
    PubMed    


  18. YOKOYAMA S, Fujita Y, Matsumura S, Yoshimura T, et al
    Cribriform carcinoma in the lymph nodes is associated with distant metastasis, recurrence, and survival among patients with node-positive colorectal cancer.
    Br J Surg. 2021 Jan 11. pii: 6082763. doi: 10.1093.
    PubMed    


    December 2020
  19. HEALEY BIRD BRJ
    Total neoadjuvant therapy for locally advanced rectal cancer: the fuse is lit.
    Br J Surg. 2020;107:1705-1707.
    PubMed    


  20. VAN OOSTENDORP SE, Smits LJH, Vroom Y, Detering R, et al
    Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment.
    Br J Surg. 2020;107:1719-1730.
    PubMed     Abstract available


  21. DENOST Q, Solomon M, Tuech JJ, Ghouti L, et al
    International variation in managing locally advanced or recurrent rectal cancer: prospective benchmark analysis.
    Br J Surg. 2020;107:1846-1854.
    PubMed     Abstract available


  22. LIGHTNER AL, Vaidya P, Vogler S, McMichael J, et al
    Surveillance pouchoscopy for dysplasia: Cleveland Clinic Ileoanal Pouch Anastomosis Database.
    Br J Surg. 2020;107:1826-1831.
    PubMed     Abstract available


  23. JORGREN F, Lydrup ML, Buchwald P
    Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Br J Surg. 2020;107:1818-1825.
    PubMed     Abstract available


    November 2020
  24. MARCHEGIANI F, Barina A, Spolverato G, Pucciarelli S, et al
    Defunctioning stoma in young patients affected by rectal cancer: a delicate balance.
    Br J Surg. 2020;107:e639.
    PubMed    


  25. HIDAYAT H, Etherson K, Shanmugam V
    Comment on: Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Br J Surg. 2020;107:e627.
    PubMed    


  26. PETROV A
    Author response to: Comment on: Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Br J Surg. 2020;107:e628.
    PubMed    


  27. JORGREN F, Lydrup ML, Buchwald P
    Author response to: Comment on: Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Br J Surg. 2020;107:e622.
    PubMed    


  28. WU Q, Jin Z, Peng Y, Wang Z, et al
    Comment on: Impact of rectal perforation on recurrence during rectal cancer surgery in a national population registry.
    Br J Surg. 2020;107:e621.
    PubMed    


  29. TUYNMAN JB, van Oostendorp SE, Kusters M, Sietses C, et al
    Author response to: TaTME and the worse oncological outcome - new data demonstrates a difficult method.
    Br J Surg. 2020;107:e612.
    PubMed    


  30. WASMUTH HH, Larsen SG, Faerden AE
    TaTME and the worse oncological outcome - new data demonstrates a difficult method.
    Br J Surg. 2020;107:e611.
    PubMed    


  31. PEACOCK O, Limvorapitak T, Hu CY, Bednarski BK, et al
    Robotic rectal cancer surgery: comparative study of the impact of obesity on early outcomes.
    Br J Surg. 2020;107:1552-1557.
    PubMed     Abstract available


  32. WILLIAMSON JS, Quyn AJ, Sagar PM
    Rectal cancer lateral pelvic sidewall lymph nodes: a review of controversies and management.
    Br J Surg. 2020;107:1562-1569.
    PubMed     Abstract available


    October 2020
  33. HUDDY JR, Freeman Z, Crockett M, Hadjievangelou N, et al
    Establishing a "cold" elective unit for robotic colorectal and urological cancer surgery and regional vascular surgery following the initial COVID-19 surge.
    Br J Surg. 2020;107:e466-e467.
    PubMed    



  34. The impact of the COVID-19 pandemic on the Management of Locally Advanced Primary/Recurrent Rectal Cancer.
    Br J Surg. 2020;107:e547-e548.
    PubMed    


  35. ZHOU X, Liu Z, Zhang D, Wu L, et al
    Improving initial nodal staging of T3 rectal cancer using quantitative image features.
    Br J Surg. 2020;107:e541-e542.
    PubMed    


  36. EFETOV SK, Lychagin AV, Zubayraeva AA, Picciariello A, et al
    3D-printed pubic bone for pelvic ring reconstruction after exenteration for anal cancer recurrence.
    Br J Surg. 2020;107:e512-e514.
    PubMed    


    September 2020
  37. MA J, Whittaker Y, Chandran P
    Male Sexual Dysfunction after Pelvic Surgery for Colorectal Cancer.
    Br J Surg. 2020 Sep 8. doi: 10.1002/bjs.12033.
    PubMed    


  38. LIYANAGE ASD, Gokul K, Babu BH, Ainsworth P, et al
    Stage migration of colorectal cancer during COVID-19 pandemic.
    Br J Surg. 2020 Sep 2. doi: 10.1002/bjs.11936.
    PubMed    


  39. BARRETT K, Habib Bedwani N, Arya S, Bhargava A, et al
    Colorectal cancer referrals during the COVID-19 pandemic - a model for the faster diagnosis standard?
    Br J Surg. 2020 Sep 1. doi: 10.1002/bjs.12008.
    PubMed    


  40. DETERING R, van Oostendorp SE, Meyer VM, van Dieren S, et al
    MRI cT1-2 rectal cancer staging accuracy: a population-based study.
    Br J Surg. 2020;107:1372-1382.
    PubMed     Abstract available


  41. SAKAMOTO T, Fujiogi M, Lefor AK, Matsui H, et al
    Stent as a bridge to surgery or immediate colectomy for malignant right colonic obstruction: propensity-scored, national database study.
    Br J Surg. 2020;107:1354-1362.
    PubMed     Abstract available


    August 2020
  42. KONTOVOUNISIOS C
    The impact of the COVID-19 pandemic on colorectal cancer service provision.
    Br J Surg. 2020 Aug 28. doi: 10.1002/bjs.11990.
    PubMed    


  43. BEHM KT, Grass F, Abd El Aziz MA, Kelley SR, et al
    Short term oncological outcomes of completely intracorporeal anastomosis after left sided robotic resections for colorectal cancer.
    Br J Surg. 2020 Aug 26. doi: 10.1002/bjs.11955.
    PubMed    


  44. TREASURE T, Leonard P, Milosevic M, Williams NR, et al
    Pulmonary Metastasectomy in Colorectal Cancer: the PulMiCC randomised controlled trial.
    Br J Surg. 2020 Aug 21. doi: 10.1002/bjs.11948.
    PubMed    


  45. DARVISH-DAMAVANDI M, Laycock J, Ward C, van Driel MS, et al
    An analysis of SARS-CoV-2 cell entry genes identifies the intestine and colorectal cancer as susceptible tissues.
    Br J Surg. 2020 Aug 10. doi: 10.1002/bjs.11911.
    PubMed    


  46. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Author response to: NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020;107:e358.
    PubMed    


  47. MARINO F, Trompetto M, Gallo G
    COVID-19 pandemic: a large boulder on the head of stoma patients.
    Br J Surg. 2020;107:e303.
    PubMed    


  48. WARRIER SK, Bell S, Guest G, Heriot A, et al
    Locoregional recurrences after transanal total mesorectal excision of rectal cancer during the exploration phase.
    Br J Surg. 2020;107:e353.
    PubMed    


  49. BERGAMASCHI R, Gachabayov M, Orangio G, Remzi F, et al
    Evidence supporting the sunk cost fallacy of advocating for transanal total mesorectal excision.
    Br J Surg. 2020;107:e347.
    PubMed    


  50. VAN OOSTENDORP SE, Sietses C, Hompes R, Kusters M, et al
    Author response to: Evidence supporting the sunk cost fallacy of advocating for transanal total mesorectal excision.
    Br J Surg. 2020;107:e348.
    PubMed    


  51. VAN OOSTENDORP SE, Belgers HJ, Bootsma BT, Hol JC, et al
    Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation.
    Br J Surg. 2020;107:1211-1220.
    PubMed     Abstract available


    July 2020
  52. CARRANO FM, Foppa C, Carvello M, Spinelli A, et al
    With adequate precautions colorectal cancer surgery can be safely continued during COVID-19 pandemic.
    Br J Surg. 2020 Jul 31. doi: 10.1002/bjs.11859.
    PubMed    


  53. CHAN DKH, Keh CHL, Seow CS, Iau PTC, et al
    Maintaining quality of care in colorectal cancer surgery during the COVID-19 pandemic.
    Br J Surg. 2020 Jul 31. doi: 10.1002/bjs.11866.
    PubMed    


  54. MAEDA Y, Dunlop MG, Din FVN
    Risk mitigation for suspected colorectal cancer diagnostic pathway during COVID-19 pandemic.
    Br J Surg. 2020 Jul 23. doi: 10.1002/bjs.11798.
    PubMed    


  55. BAUM M, Fallowfield L, Farewell V, Macbeth F, et al
    NICE Guidelines: management of colorectal cancer metastases.
    Br J Surg. 2020 Jul 11. doi: 10.1002/bjs.11789.
    PubMed    


  56. MIRNEZAMI R, Knowles J, Kar A, Glynne-Jones R, et al
    Preoperative radiotherapy for locally advanced rectal cancer during and after the COVID-19 pandemic.
    Br J Surg. 2020;107:e263.
    PubMed    


  57. GIANI I, Elbetti C, Trompetto M, Gallo G, et al
    Proctology in the COVID-19 era: handle with care.
    Br J Surg. 2020;107:e243.
    PubMed    


  58. TSUKAMOTO S, Fujita S, Kanemitsu Y
    Author response to: Beyond T, N and M: can lateral lymph node dissection treat tumour deposits in advanced low rectal carcinoma?
    Br J Surg. 2020;107:e291.
    PubMed    


  59. PEPARINI N
    Beyond T, N and M: can lateral lymph node dissection treat tumour deposits in advanced low rectal carcinoma?
    Br J Surg. 2020;107:e290.
    PubMed    


  60. PEREA J, Garcia JL, Garcia-Olmo D, Urioste M, et al
    Comment on: Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer.
    Br J Surg. 2020;107:e277.
    PubMed    


    June 2020
  61. TUTTON MG
    Colorectal cancer surgery during the COVID-19 pandemic.
    Br J Surg. 2020 Jun 3. doi: 10.1002/bjs.11734.
    PubMed    


  62. D'SOUZA N, Abulafi M
    Navigating the storm of COVID-19 for patients with suspected bowel cancer.
    Br J Surg. 2020;107:e204.
    PubMed    


  63. LACY AM, De Lacy FB, Balibrea JM
    Considerations for transanal total mesorectal excision (TaTME) use during the COVID-19 pandemic.
    Br J Surg. 2020;107:e203.
    PubMed    


  64. WARRIER SK, Bell S, Kong JC, Larach T, et al
    Comments on: Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
    Br J Surg. 2020;107:e221.
    PubMed    


  65. LARSEN SG, Faerden AE, Wasmuth HH
    Author response to: Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway.
    Br J Surg. 2020;107:e222.
    PubMed    


  66. WASMUTH HH, Faerden AE, Larsen SG
    Author response to: Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway.
    Br J Surg. 2020;107:e224.
    PubMed    


  67. SEOW-EN I, Seow-Choen F
    Comment on: Transanal total mesorectal excision for rectal cancer has been abandoned in Norway.
    Br J Surg. 2020;107:e223.
    PubMed    


  68. CRIPPA J, Grass F, Larson DW
    Author response to: Is robotic approach associated with a lower risk of conversion in rectal cancer surgery compared with laparoscopic approach?
    Br J Surg. 2020;107:e227.
    PubMed    


  69. YANG TH, Shen Y
    Comment on: Risk factors for conversion in laparoscopic and robotic rectal cancer surgery.
    Br J Surg. 2020;107:e225.
    PubMed    


  70. JIA HD, Diao YK, Li C, Liang L, et al
    Is robotic approach associated with a lower risk of conversion in rectal cancer surgery compared with laparoscopic approach?
    Br J Surg. 2020;107:e226.
    PubMed    


  71. SOCHA J, Bujko K
    Should a minimum 8-week interval between preoperative radiotherapy and surgery become the standard of care? No, it shouldn't.
    Br J Surg. 2020;107:e211-e212.
    PubMed    


  72. RYAN EJ, O'Riordan JM, Winter DC
    Author response to: Should a minimum 8-week interval between preoperative radiotherapy and surgery become the standard of care? No, it shouldn't.
    Br J Surg. 2020;107:e213-e214.
    PubMed    


    May 2020
  73. ALTAF K, Tan J, Parvaiz A, Ahmed S, et al
    Impact on colorectal cancer in COVID-19 pandemic.
    Br J Surg. 2020 May 29. doi: 10.1002/bjs.11720.
    PubMed    



  74. Colorectal cancer services during the COVID-19 pandemic.
    Br J Surg. 2020 May 22. doi: 10.1002/bjs.11706.
    PubMed    


  75. MOHAMED F, Kallioinen M, Braun M, Fenwick S, et al
    Management of colorectal cancer metastases to the liver, lung or peritoneum suitable for curative intent: summary of NICE guidance.
    Br J Surg. 2020 May 9. doi: 10.1002/bjs.11609.
    PubMed    


  76. DIAO YK, Liang L, Li C, Zhang CW, et al
    Is there a causal relationship between blood cultures after surgery for colorectal cancer and long-term oncological outcomes?
    Br J Surg. 2020;107:773.
    PubMed    


    April 2020
  77. CULLINANE CM, Creavin B, O'Connell EP, Kelly L, et al
    Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis.
    Br J Surg. 2020 Apr 16. doi: 10.1002/bjs.11603.
    PubMed     Abstract available


  78. KATAOKA K, Beppu N, Shiozawa M, Ikeda M, et al
    Colorectal cancer treated by resection and extended lymphadenectomy: patterns of spread in left- and right-sided tumours.
    Br J Surg. 2020 Apr 4. doi: 10.1002/bjs.11517.
    PubMed     Abstract available


  79. DENOST Q
    The challenge posed by young-onset rectal cancer.
    Br J Surg. 2020;107:481-483.
    PubMed    


  80. TSUKAMOTO S, Fujita S, Ota M, Mizusawa J, et al
    Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212).
    Br J Surg. 2020;107:586-594.
    PubMed     Abstract available


  81. VAN DER HEIJDEN JAG, Koeter T, Smits LJH, Sietses C, et al
    Functional complaints and quality of life after transanal total mesorectal excision: a meta-analysis.
    Br J Surg. 2020;107:489-498.
    PubMed     Abstract available


  82. NG KS, Russo R, Gladman MA
    Colonic transit in patients after anterior resection: prospective, comparative study using single-photon emission CT/CT scintigraphy.
    Br J Surg. 2020;107:567-579.
    PubMed     Abstract available


  83. ZABOROWSKI AM, Murphy B, Creavin B, Rogers AC, et al
    Clinicopathological features and oncological outcomes of patients with young-onset rectal cancer.
    Br J Surg. 2020;107:606-612.
    PubMed     Abstract available


  84. AGGER EA, Jorgren FH, Lydrup MA, Buchwald PL, et al
    Risk of local recurrence of rectal cancer and circumferential resection margin: population-based cohort study.
    Br J Surg. 2020;107:580-585.
    PubMed     Abstract available


  85. KOK END, Havenga K, Tanis PJ, de Wilt JHW, et al
    Multicentre study of short-course radiotherapy, systemic therapy and resection/ablation for stage IV rectal cancer.
    Br J Surg. 2020;107:537-545.
    PubMed     Abstract available


  86. CRIPPA J, Grass F, Achilli P, Mathis KL, et al
    Risk factors for conversion in laparoscopic and robotic rectal cancer surgery.
    Br J Surg. 2020;107:560-566.
    PubMed     Abstract available


  87. GRASS F, Hubner M, Mathis KL, Hahnloser D, et al
    Identification of patients eligible for discharge within 48 h of colorectal resection.
    Br J Surg. 2020;107:546-551.
    PubMed     Abstract available


  88. KARACHUN A, Panaiotti L, Chernikovskiy I, Achkasov S, et al
    Short-term outcomes of a multicentre randomized clinical trial comparing D2 versus D3 lymph node dissection for colonic cancer (COLD trial).
    Br J Surg. 2020;107:499-508.
    PubMed     Abstract available


  89. SVANSTROM ROJVALL A, Buchli C, Bottai M, Ahlberg M, et al
    Effect of radiotherapy for rectal cancer on female sexual function: a prospective cohort study.
    Br J Surg. 2020;107:525-536.
    PubMed    


    March 2020
  90. CHAMBERS AC, Dixon SW, White P, Williams AC, et al
    Demographic trends in the incidence of young-onset colorectal cancer: a population-based study.
    Br J Surg. 2020 Mar 9. doi: 10.1002/bjs.11486.
    PubMed     Abstract available


  91. RONCATI L, Manenti A, ZIzzo M, Farinetti A, et al
    Comment on: Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision.
    Br J Surg. 2020;107:464.
    PubMed    


  92. MERKEL S, Hohenberger W
    Author response to: Comment on: Prognosis of patients with colonic carcinoma before, during and after implementation of complete mesocolic excision.
    Br J Surg. 2020;107:464.
    PubMed    


    February 2020
  93. KOBAYASHI M, Kako J, Kajiwara K, Oosono Y, et al
    Comment on: Predicting return to work among patients with colorectal cancer.
    Br J Surg. 2020;107:318.
    PubMed    


    January 2020
  94. ALMAZEEDI S, El-Abd R, Al-Khamis A, Albatineh AN, et al
    Role of bariatric surgery in reducing the risk of colorectal cancer: a meta-analysis.
    Br J Surg. 2020 Jan 24. doi: 10.1002/bjs.11494.
    PubMed     Abstract available


  95. SCHAAP DP, de Valk KS, Deken MM, Meijer RPJ, et al
    Carcinoembryonic antigen-specific, fluorescent image-guided cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for metastatic colorectal cancer.
    Br J Surg. 2020 Jan 21. doi: 10.1002/bjs.11523.
    PubMed     Abstract available


  96. SARASTE D, Jaras J, Martling A
    Population-based analysis of outcomes with early-age colorectal cancer.
    Br J Surg. 2020 Jan 10. doi: 10.1002/bjs.11333.
    PubMed     Abstract available


  97. XU YJ, Sun X, Jiang H, Yin YH, et al
    Randomized clinical trial of continuous transversus abdominis plane block, epidural or patient-controlled analgesia for patients undergoing laparoscopic colorectal cancer surgery.
    Br J Surg. 2020;107:e133-e141.
    PubMed     Abstract available


  98. RYAN EJ, O'Riordan JM, Winter DC
    Author response to: Comment on: Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.
    Br J Surg. 2020;107:151-152.
    PubMed    


  99. HAJIBANDEH S, Hajibandeh S
    Comment on: Meta-analysis of the effect of extending the interval after long-course chemoradiotherapy before surgery in locally advanced rectal cancer.
    Br J Surg. 2020;107:151.
    PubMed    


  100. WASMUTH HH, Faerden AE, Myklebust TA, Pfeffer F, et al
    Transanal total mesorectal excision for rectal cancer has been suspended in Norway.
    Br J Surg. 2020;107:121-130.
    PubMed     Abstract available


  101. VAN DER SLUIS FJ, Couwenberg AM, de Bock GH, Intven MPW, et al
    Population-based study of morbidity risk associated with pathological complete response after chemoradiotherapy for rectal cancer.
    Br J Surg. 2020;107:131-139.
    PubMed     Abstract available


    December 2019
  102. LARSEN SG, Pfeffer F, Korner H
    Author response to: Comments on: Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1855.
    PubMed    


  103. LACY AM, Nogueira ST, de Lacy FB
    Comment on: Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1855.
    PubMed    


    November 2019
  104. WATT SK, Fransgaard T, Degett TH, Thygesen LC, et al
    Associations between blood cultures after surgery for colorectal cancer and long-term oncological outcomes.
    Br J Surg. 2019 Nov 22. doi: 10.1002/bjs.11372.
    PubMed     Abstract available


    October 2019
  105. DEN BAKKER CM, Anema JR, Huirne JAF, Twisk J, et al
    Predicting return to work among patients with colorectal cancer.
    Br J Surg. 2019 Oct 25. doi: 10.1002/bjs.11313.
    PubMed     Abstract available


  106. ZABOROWSKI A, Stakelum A, Winter DC
    Author response to: Total neoadjuvant therapy in rectal cancer-improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    PubMed    


  107. MROCZKOWSKI P, Dziki L
    Total neoadjuvant therapy in rectal cancer - improvement or overtreatment?
    Br J Surg. 2019;106:1558.
    PubMed    


    August 2019
  108. GARLIPP B, Gibbs P, Van Hazel GA, Jeyarajah R, et al
    Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
    Br J Surg. 2019 Aug 19. doi: 10.1002/bjs.11283.
    PubMed     Abstract available


  109. LARSEN SG, Pfeffer F, Korner H
    Norwegian moratorium on transanal total mesorectal excision.
    Br J Surg. 2019;106:1120-1121.
    PubMed    


  110. PUCCIARELLI S, Del Bianco P, Pace U, Bianco F, et al
    Multicentre randomized clinical trial of colonic J pouch or straight stapled colorectal reconstruction after low anterior resection for rectal cancer.
    Br J Surg. 2019;106:1147-1155.
    PubMed     Abstract available


  111. ERLANDSSON J, Pettersson D, Glimelius B, Holm T, et al
    Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy.
    Br J Surg. 2019;106:1248-1256.
    PubMed     Abstract available


  112. BACHET JB, Moreno-Lopez N, Vigano L, Marchese U, et al
    BRAF mutation is not associated with an increased risk of recurrence in patients undergoing resection of colorectal liver metastases.
    Br J Surg. 2019;106:1237-1247.
    PubMed     Abstract available


    July 2019
  113. ROTTIER SJ, van Dijk ST, van Geloven AAW, Schreurs WH, et al
    Meta-analysis of the role of colonoscopy after an episode of left-sided acute diverticulitis.
    Br J Surg. 2019;106:988-997.
    PubMed     Abstract available


  114. LAKKIS Z, Vernerey D, Mege D, Faucheron JL, et al
    Morbidity and oncological outcomes of rectal cancer impaired by previous prostate malignancy.
    Br J Surg. 2019;106:1087-1098.
    PubMed     Abstract available


  115. ZABOROWSKI A, Stakelum A, Winter DC
    Systematic review of outcomes after total neoadjuvant therapy for locally advanced rectal cancer.
    Br J Surg. 2019;106:979-987.
    PubMed     Abstract available


  116. AMELUNG FJ, Borstlap WAA, Consten ECJ, Veld JV, et al
    Propensity score-matched analysis of oncological outcome between stent as bridge to surgery and emergency resection in patients with malignant left-sided colonic obstruction.
    Br J Surg. 2019;106:1075-1086.
    PubMed     Abstract available


    June 2019
  117. BEDNARSKI BK, Nickerson TP, You YN, Messick CA, et al
    Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial).
    Br J Surg. 2019 Jun 19. doi: 10.1002/bjs.11223.
    PubMed     Abstract available


  118. SILLO TO, Beggs AD, Morton DG, Middleton G, et al
    Mechanisms of immunogenicity in colorectal cancer.
    Br J Surg. 2019 Jun 19. doi: 10.1002/bjs.11204.
    PubMed     Abstract available


  119. HAMID HKS
    Correspondence.
    Br J Surg. 2019;106:949-950.
    PubMed    


  120. DUCHALAIS E, Larson DW
    Correspondence.
    Br J Surg. 2019;106:950-951.
    PubMed    



  121. Snapshot quiz.
    Br J Surg. 2019;106:836.
    PubMed    


  122. QUIRAM BJ, Crippa J, Grass F, Lovely JK, et al
    Impact of enhanced recovery on oncological outcomes following minimally invasive surgery for rectal cancer.
    Br J Surg. 2019;106:922-929.
    PubMed     Abstract available


    May 2019
  123. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
    Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Br J Surg. 2019;106:728.
    PubMed    


  124. WESTBERG K, Palmer G, Hjern F, Holm T, et al
    Population-based study of surgical treatment with and without tumour resection in patients with locally recurrent rectal cancer.
    Br J Surg. 2019;106:790-798.
    PubMed     Abstract available


  125. VAN DER POEL MJ, Barkhatov L, Fuks D, Berardi G, et al
    Multicentre propensity score-matched study of laparoscopic versus open repeat liver resection for colorectal liver metastases.
    Br J Surg. 2019;106:783-789.
    PubMed     Abstract available


    April 2019
  126. REYNOLDS IS, Furney SJ, Kay EW, McNamara DA, et al
    Meta-analysis of the molecular associations of mucinous colorectal cancer.
    Br J Surg. 2019 Apr 4. doi: 10.1002/bjs.11142.
    PubMed     Abstract available


  127. KEANE C, Park J, Oberg S, Wedin A, et al
    Functional outcomes from a randomized trial of early closure of temporary ileostomy after rectal excision for cancer.
    Br J Surg. 2019;106:645-652.
    PubMed     Abstract available


    March 2019
  128. ABIS GSA, Stockmann HBAC, Bonjer HJ, van Veenendaal N, et al
    Randomized clinical trial of selective decontamination of the digestive tract in elective colorectal cancer surgery (SELECT trial).
    Br J Surg. 2019;106:355-363.
    PubMed     Abstract available



  129. Snapshot quiz.
    Br J Surg. 2019;106:341.
    PubMed    


  130. KELLER DS, Reali C, Spinelli A, Penna M, et al
    Patient-reported functional and quality-of-life outcomes after transanal total mesorectal excision.
    Br J Surg. 2019;106:364-366.
    PubMed     Abstract available


  131. LAU YC, Jongerius K, Wakeman C, Heriot AG, et al
    Influence of the level of sacrectomy on survival in patients with locally advanced and recurrent rectal cancer.
    Br J Surg. 2019;106:484-490.
    PubMed     Abstract available


  132. VAN 'T SANT I, van Eden WJ, Engbersen MP, Kok NFM, et al
    Diffusion-weighted MRI assessment of the peritoneal cancer index before cytoreductive surgery.
    Br J Surg. 2019;106:491-498.
    PubMed     Abstract available


  133. AHL R, Matthiessen P, Fang X, Cao Y, et al
    Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery.
    Br J Surg. 2019;106:477-483.
    PubMed     Abstract available


    February 2019
  134. SEGELMAN J, Buchli C, Svanstrom Rojvall A, Matthiessen P, et al
    Effect of radiotherapy for rectal cancer on ovarian androgen production.
    Br J Surg. 2019;106:267-275.
    PubMed    


    January 2019
  135. BJORNELV GMW, Dueland S, Line PD, Joranger P, et al
    Cost-effectiveness of liver transplantation in patients with colorectal metastases confined to the liver.
    Br J Surg. 2019;106:132-141.
    PubMed     Abstract available


  136. ELFEKI H, Larsen HM, Emmertsen KJ, Christensen P, et al
    Bowel dysfunction after sigmoid resection for cancer and its impact on quality of life.
    Br J Surg. 2019;106:142-151.
    PubMed     Abstract available


    November 2018
  137. KOSKENVUO L, Malila N, Pitkaniemi J, Miettinen J, et al
    Sex differences in faecal occult blood test screening for colorectal cancer.
    Br J Surg. 2018 Nov 21. doi: 10.1002/bjs.11011.
    PubMed     Abstract available


    August 2018
  138. BARE M, Mora L, Tora N, Gil MJ, et al
    CCR-CARESS score for predicting operative mortality in patients with colorectal cancer.
    Br J Surg. 2018 Aug 13. doi: 10.1002/bjs.10956.
    PubMed     Abstract available


  139. MARGONIS GA, Sasaki K, Gholami S, Kim Y, et al
    Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
    Br J Surg. 2018;105:1210-1220.
    PubMed     Abstract available


  140. OKUNO M, Goumard C, Mizuno T, Kopetz S, et al
    Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Br J Surg. 2018;105:1200-1209.
    PubMed     Abstract available


    May 2018

  141. Advanced colorectal cancer issue.
    Br J Surg. 2018;105:E240-E247.
    PubMed    


  142. BROWN KGM, Solomon MJ
    Progress and future direction in the management of advanced colorectal cancer.
    Br J Surg. 2018;105:615-617.
    PubMed    


  143. PASSOT G, Dumont F, Goere D, Arvieux C, et al
    Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE).
    Br J Surg. 2018;105:663-667.
    PubMed     Abstract available


  144. YAMASHITA S, Chun YS, Kopetz SE, Vauthey JN, et al
    Biomarkers in colorectal liver metastases.
    Br J Surg. 2018;105:618-627.
    PubMed     Abstract available



  145. Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer.
    Br J Surg. 2018;105:650-657.
    PubMed     Abstract available


    April 2018
  146. QUYN AJ, Fraser CG, Rodger J, Digan A, et al
    Participation in bowel screening among men attending abdominal aortic aneurysm screening.
    Br J Surg. 2018;105:529-534.
    PubMed     Abstract available


    March 2018
  147. SHINKINS B, Primrose JN, Pugh SA, Nicholson BD, et al
    Serum carcinoembryonic antigen trends for diagnosing colorectal cancer recurrence in the FACS randomized clinical trial.
    Br J Surg. 2018 Mar 26. doi: 10.1002/bjs.10819.
    PubMed     Abstract available


  148. DUELAND S, Foss A, Solheim JM, Hagness M, et al
    Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma.
    Br J Surg. 2018 Mar 13. doi: 10.1002/bjs.10769.
    PubMed     Abstract available


  149. VAN ZOGGEL DMGI, Bosman SJ, Kusters M, Nieuwenhuijzen GAP, et al
    Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.
    Br J Surg. 2018;105:447-452.
    PubMed     Abstract available


    February 2018
  150. PARK J, Danielsen AK, Angenete E, Bock D, et al
    Quality of life in a randomized trial of early closure of temporary ileostomy after rectal resection for cancer (EASY trial).
    Br J Surg. 2018;105:244-251.
    PubMed     Abstract available


  151. GRUT H, Solberg S, Seierstad T, Revheim ME, et al
    Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases.
    Br J Surg. 2018;105:295-301.
    PubMed     Abstract available


    January 2018
  152. ESCAL L, Nougaret S, Guiu B, Bertrand MM, et al
    MRI-based score to predict surgical difficulty in patients with rectal cancer.
    Br J Surg. 2018;105:140-146.
    PubMed     Abstract available


  153. UBINK I, van Eden WJ, Snaebjornsson P, Kok NFM, et al
    Histopathological and molecular classification of colorectal cancer and corresponding peritoneal metastases.
    Br J Surg. 2018;105:e204-e211.
    PubMed     Abstract available


  154. MARKS KM, West NP, Morris E, Quirke P, et al
    Clinicopathological, genomic and immunological factors in colorectal cancer prognosis.
    Br J Surg. 2018;105:e99-e109.
    PubMed     Abstract available


  155. RYAN EJ, Creagh EM
    Emerging methods in colorectal cancer screening.
    Br J Surg. 2018;105:e16-e18.
    PubMed    


  156. GAINES S, Shao C, Hyman N, Alverdy JC, et al
    Gut microbiome influences on anastomotic leak and recurrence rates following colorectal cancer surgery.
    Br J Surg. 2018;105:e131-e141.
    PubMed     Abstract available


  157. KOYAMA FC, Lopes Ramos CM, Ledesma F, Alves VAF, et al
    Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
    Br J Surg. 2018;105:e192-e203.
    PubMed     Abstract available


    December 2017
  158. WESTBERG K, Palmer G, Hjern F, Nordenvall C, et al
    Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer.
    Br J Surg. 2017;104:1866-1873.
    PubMed     Abstract available


    November 2017
  159. CREAVIN B, Kelly ME, Ryan E, Winter DC, et al
    Meta-analysis of the impact of surgical approach on the grade of mesorectal excision in rectal cancer.
    Br J Surg. 2017;104:1609-1619.
    PubMed     Abstract available


  160. DIEDEREN K, Sahami SS, Tabbers MM, Benninga MA, et al
    Outcome after restorative proctocolectomy and ileal pouch-anal anastomosis in children and adults.
    Br J Surg. 2017;104:1640-1647.
    PubMed     Abstract available


    October 2017
  161. NITSCHE U, Stoss C, Stecher L, Wilhelm D, et al
    Meta-analysis of outcomes following resection of the primary tumour in patients presenting with metastatic colorectal cancer.
    Br J Surg. 2017 Oct 31. doi: 10.1002/bjs.10682.
    PubMed     Abstract available


  162. ELLEBAEK SB, Fristrup CW, Hovendal C, Qvist N, et al
    Randomized clinical trial of laparoscopic ultrasonography before laparoscopic colorectal cancer resection.
    Br J Surg. 2017;104:1462-1469.
    PubMed     Abstract available


    February 2017
  163. MARTLING A, Smedby KE, Birgisson H, Olsson H, et al
    Risk of second primary cancer in patients treated with radiotherapy for rectal cancer.
    Br J Surg. 2017;104:278-287.
    PubMed     Abstract available


  164. HAIN E, Maggiori L, Manceau G, Mongin C, et al
    Oncological impact of anastomotic leakage after laparoscopic mesorectal excision.
    Br J Surg. 2017;104:288-295.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: